These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 1970634)

  • 1. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene.
    Tomita Y; Takeda A; Okinaga S; Tagami H; Shibahara S
    Biochem Biophys Res Commun; 1989 Nov; 164(3):990-6. PubMed ID: 2511845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosinase-positive oculocutaneous albinism locus is not linked to the beta-globin locus in man.
    Heim RA; Dunn DS; Candy SE; Zwane E; Kromberg JG; Jenkins T
    Hum Genet; 1988 May; 79(1):89. PubMed ID: 3130302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
    Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
    Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice.
    Beermann F; Ruppert S; Hummler E; Bosch FX; Müller G; Rüther U; Schütz G
    EMBO J; 1990 Sep; 9(9):2819-26. PubMed ID: 2118105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant.
    Jackson IJ; Bennett DC
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7010-4. PubMed ID: 2119500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual evoked potentials in Negro carriers of the gene for tyrosinase positive oculocutaneous albinism.
    Castle D; Kromberg J; Kowalsky R; Moosa R; Gillman N; Zwane E; Fritz V
    J Med Genet; 1988 Dec; 25(12):835-7. PubMed ID: 3148727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location.
    King RA; Olds DP
    Am J Med Genet; 1985 Jan; 20(1):49-55. PubMed ID: 3918447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine----serine substitution at position 85.
    Shibahara S; Okinaga S; Tomita Y; Takeda A; Yamamoto H; Sato M; Takeuchi T
    Eur J Biochem; 1990 Apr; 189(2):455-61. PubMed ID: 2110899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene.
    Shimizu H; Niizeki H; Suzumori K; Aozaki R; Kawaguchi R; Hikiji K; Nishikawa T
    J Invest Dermatol; 1994 Jul; 103(1):104-6. PubMed ID: 8027570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of point mutation in the tyrosinase gene of a Japanese albino patient by a direct sequencing of amplified DNA.
    Kikuchi H; Hara S; Ishiguro S; Tamai M; Watanabe M
    Hum Genet; 1990 Jun; 85(1):123-4. PubMed ID: 2113511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
    Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.